Effectiveness of Rotavirus Immunization in Nicaragua
NCT01133808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 667
Last updated 2011-09-09
Summary
The purpose of the investigators study is to compare the rates of childhood diarrhea at the community level before and after the rotavirus vaccination program in León, Nicaragua. From preliminary studies, the investigators anticipate about a 28% reduction in diarrhea following the vaccination program among children who received the vaccine, and a smaller reduction in diarrhea among children who did not receive the vaccine, due to the effects of "herd immunity". In addition, the investigators will collect stool samples from children who develop diarrhea in order determine the etiology of childhood diarrhea in the post-rotavirus immunization era.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
-
Thrasher Research Fund
collaborator OTHER -
Fogarty International Center of the National Institute of Health
collaborator NIH -
Sylvia Becker-Dreps
lead OTHER
Principal Investigators
-
Sylvia Becker-Dreps, MD · University of North Carolina, Chapel Hill
Eligibility
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2011-01-31
- Completion
- 2011-01-31
More Related Trials
-
ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage
NCT06882070 ·Status: COMPLETED
-
Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants
NCT00655187 ·Status: COMPLETED
-
Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules
NCT01266850 ·Status: COMPLETED ·Phase: PHASE4
-
ROTATEQ Reexamination Study (V260-037)
NCT01074242 ·Status: COMPLETED
-
Causes of Rotavirus Vaccine Failure in Zambian Children
NCT01886833 ·Status: COMPLETED
-
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
NCT01026779 ·Status: COMPLETED
-
Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model
NCT04123119 ·Status: COMPLETED ·Phase: NA
-
Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)
NCT00329745 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination
NCT01915888 ·Status: COMPLETED
-
The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity
NCT02992197 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
NCT06200844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Developing World Study for RotaTeq™ (V260-015)(COMPLETED)
NCT00362648 ·Status: COMPLETED ·Phase: PHASE3
-
Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization
NCT05032391 ·Status: COMPLETED ·Phase: PHASE3
-
Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium
NCT01339221 ·Status: COMPLETED
-
Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study
NCT02542462 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children
NCT02556996 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study
NCT03271593 ·Status: COMPLETED
-
Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™
NCT01511133 ·Status: COMPLETED
-
Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants
NCT00280111 ·Status: COMPLETED ·Phase: PHASE1
-
Phase III Study of Liquid Formulation of ROTAVIN
NCT03703336 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)
NCT01600092 ·Status: COMPLETED ·Phase: PHASE3
-
Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa
NCT04658914 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis
NCT01978223 ·Status: WITHDRAWN
-
Gastroenteritis From Rotavirus Infection in Brazilian Children Less Than 5 Years of Age (Study V260-031).
NCT01195844 ·Status: TERMINATED
-
Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
NCT06350058 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1